Kaposi's sarcoma is not a neoplasm let alone a sarcoma

International Journal of Dermatology

Volumn 42, Issue 10, 2003, Pages 844-845

  Pérez, Aivlys ^a   Sánchez, Jorge L ^a   Almodóvar, Pablo I ^a  

^a UNIVERSITY OF PUERTO RICO SCHOOL OF MEDICINE   (Puerto Rico)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; ANTIBODY; ANTINEOPLASTIC AGENT; ANTIRETROVIRUS AGENT; ANTIVIRUS AGENT; CIDOFOVIR; CYTOKINE; FOSCARNET; IMMUNOMODULATING AGENT; IMMUNOSUPPRESSIVE AGENT; VIRUS PROTEIN;

CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURGERY; CELL PROLIFERATION; CONFERENCE PAPER; DISEASE COURSE; DNA SEQUENCE; DRUG WITHDRAWAL; ENDOTHELIUM CELL; HERPES VIRUS INFECTION; HISTOPATHOLOGY; HUMAN; HUMAN HERPESVIRUS 8; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERPLASIA; IMMUNE SYSTEM; KAPOSI SARCOMA; MALIGNANT NEOPLASTIC DISEASE; SKIN NODULE; SYSTEMIC DISEASE; VIRUS GENOME;

AIDS-RELATED OPPORTUNISTIC INFECTIONS; HERPESVIRUS 8, HUMAN; HUMANS; SARCOMA, KAPOSI;

EID: 0142217997     PISSN: 00119059     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-4362.2003.01960.x     Document Type: Article

References (13)

1. Kaposi M. Idiopathic multiple pigmented sarcoma of the skin. CA-A Cancer J Clin 1982; 32: 342-347.
2. Chang Y, Cesarman E, Pessin MS, et al. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science 1994; 266: 1865-1869.
3. Li JJ, Huang YQ, Cockerell CJ, et al. Localization of human herpes-like virus type 8 in vascular endothelial cells and perivascular spindle-shaped cells of Kaposi's sarcoma lesions by in situ hybridization. Am J Pathol 1996; 148: 1741-1748.
4. Humphrey RW, O'Brien TR, Newcomb FM, et al. Kaposi's sarcoma-associated herpesvirus-like DNA sequences in peripheral blood mononuclear cells: Association with KS and persistence in patients receiving anti-herpesvirus drugs. Blood 1996; 88: 297-301.
5. Touloumi G, Hatzakis A, Potouridou IA, et al. The role of immunosuppression and immune activation in classic Kaposi's sarcoma. Int J Cancer 1999; 82: 817-821.
6. Antman K, Chan Y. Kaposi's sarcoma. N Eng J Med 2000; 342: 1027-1038.
7. Cotter MA, Robertson ES. Molecular biology of Kaposi's sarcoma-associated herpesvirus. Front Biosci 2002; 7: 358-375.
8. Dezube BJ. New therapies for the treatment of AIDS-related Kaposi's sarcoma. Curr Opin Oncol 2000; 12: 445-449.
9. Monini P, Sirianni MC, Franco M, et al. Clearance of human herpesvirus 8 from blood and regression of leukopenia-associated aggressive classic Kaposi's sarcoma during interferon-α therapy: A case report. Clin Infect Dis 2001; 33: 1782-1785.
10. Requena L, Sangueza OP. Cutaneous vascular proliferations. Part II. Hyperplasias and benign neoplasm. J Am Acad Dermatol 1997; 37: 887-920.
11. Azzarelli A, Mazzaferro V, Quagliuolo V, et al. Kaposi's sarcoma: Malignant tumor or proliferative disorder? Eur J Cancer Clin Oncol 1988; 24: 973-978.
12. Rabkin CS, Janz S, Lash A, et al. Monoclonal origin of multicentric Kaposi's sarcoma lesions. N Engl J Med 1997; 336: 988-993.
13. Gill PS, Tsai YC, Rao AP, et al. Evidence for multiclonality in multicentric Kaposi's sarcoma. Proc Natl Acad Sci USA 1998; 95: 8257-8261.